Radiation Dose Management Market

Radiation Dose Management Market [Product and Services: Software (Integrated Solution, Standalone Solution), Services; End-user: Hospitals, Ambulatory Care Settings, Research Organizations, Others] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Radiation Dose Management Market Outlook 2031

  • The industry was valued at US$ 237.8 Mn in 2022
  • It is estimated to advance at a CAGR of 14.8% from 2023 to 2031 and reach US$ 808.4 Mn by the end of 2031

Analyst Viewpoint

Growth in health concerns over radiation exposure and rise in use of diagnostic imaging modalities are fueling the radiation dose management market size. Radiation dose management enables optimum monitoring of dosage and high accuracy in results. Rise in number of pediatric imaging procedures is also propelling market progress.

Technological advancements and easy access to radiology screening are offering lucrative radiation dose management market opportunities to companies. Leading companies in the market are forming partnerships and alliances to increase their market presence. Increase in investments in research and development activities enables companies to offer precise dose management services to diagnosis centers.

Radiation Dose Management Market

Market Introduction

Radiation dose is the amount of energy from radiation that is actually absorbed by the body. It is important to monitor and track the amount of radiation dose injected into the body while conducting a medical procedure. Excessive dosage can create a hazardous impact on patients and also affect the results of a scan. Radiation dose management helps improve radiation protection in medical imaging and interventions. Detection of events, optimization, and imaging quality analysis are major tasks of radiation dose management.

Radiation dose management systems are widely utilized in medical imaging processes, including computed tomography, magnetic resonance imaging, and X-rays. Automatic registration and management of patient doses, information on recurrent examinations, and creation of dose reports are some of the major advantages of radiation dose management. Radiation doses help prevent adverse effects of radiation on the human body.

Increase in Health Concerns over Radiation Exposure Fostering Radiation Dose Management Market Growth

Excessive exposure to radiation can damage the DNA in cells. High doses of radiation can cause Acute Radiation Syndrome (ARS) or Cutaneous Radiation Injuries (CRI) and could also lead to cancer later in life. Radiation dose management helps to analyze the amount of doses required for medical imaging, depending on the duration, patient condition, and area to be diagnosed. Rise in various health concerns caused due to radiation exposure and increase in awareness about the benefits of these systems are major radiation dose management market drivers.

Increase in number of pediatric imaging procedures due to rise in health concerns among newborns is driving the demand for radiation dose management in pediatric radiology. Children are more susceptible to the potentially hazardous effects of ionizing radiation, thereby fostering market expansion.

Rise in Use of Diagnostic Imaging Modalities Augmenting Market Statistics

Diagnostic imaging modalities include radiotherapy, nuclear medicine, ultrasound, medical radiation, X-rays, angiography, and Magnetic Resonance Imaging (MRI). Radiation dose management is required to monitor the appropriate dosage level according to diagnosis procedure and patient’s age. Increase in availability of radiology diagnosis procedures and rise in use of diagnostic imaging modalities are fueling the radiation dose management market development. Moreover, increase in prevalence of cancer, orthopedic, and cardiac diseases is driving market dynamics.

According to the International Agency for Research on Cancer (IARC), in 2020, around 2.3 million women were diagnosed with breast cancer, with 685,000 fatalities recorded globally. The incidence of breast cancer is projected to reach 2.74 million cases by 2030.

Regional Outlook

As per the latest radiation dose management market insights, North America dominated the global market in 2022. Well-established healthcare infrastructure, increase in awareness about radiation exposure, and technological advancements in medical diagnosis are likely to propel the radiation dose management industry share held by the region during the forecast period.

According to American Cancer Society Recommendations for the Early Detection of Cancer, women aged 40-54 should undergo regular screening mammography starting at age 45. Thus, increase in number of cancer screening procedures is driving the radiation dose management market revenue.

Analysis of Key Players in Radiation Dose Management Industry

Leading companies providing radiation dose management services are collaborating with healthcare and diagnosis organizations to develop advanced services that ensure patient comfort and offer precise diagnosis results. Key players in the market are revising their marketing strategies in order to consolidate their position in the global market.

Some of the players in the industry are Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV.

Key players in the radiation dose management market report have been profiled based on various parameters including company overview, business segments, product portfolio, recent developments, business strategies, and financial overview.

Key Developments

  • In October 2022, Aspekt Solutions, a leader in medical physics services, acquired Landauer, a provider of physics and dosimetry services to radiation oncology clinics across the United States. This acquisition allows companies to provide extensive services to diagnostics centers and healthcare organizations across the U.S.
  • In September 2022, INFINITT Healthcare Co. Ltd., a leading developer of enterprise imaging solutions for healthcare, collaborated with Hamamatsu Corporation, a leading manufacturer of devices for the generation and measurement of visible, infrared, and ultraviolet light, to promote Hamamatsu whole slide scanners (NanoZoomers*) and INFINITT Digital Pathology Solution (IDPS) to its United States customers.

Radiation Dose Management Market Snapshot

Attribute Detail
Market Size in 2022 US$ 237.8 Mn
Market Forecast (Value) in 2031 US$ 808.4 Mn
Growth Rate (CAGR) 14.8%
Forecast Period 2023-2031
Historical Data Available for 2017-2021
Quantitative Tons US$ Mn for Value
Market Analysis It includes segment analysis as well as regional level analysis. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces Analysis, value chain analysis, and key trend analysis.
Competition Landscape
  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy and recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • Product and Services
    • Software
      • Integrated Solution
      • Standalone Solution
    • Services
  • Modality
    • Computed Tomography
    • Radiography and Mammography
    • Fluoroscopy and Interventional Imaging
    • Nuclear Medicine Scan
    • Others
  • Application
    • Oncology
    • Cardiology
    • Orthopedic
    • Others
  • End-user
    • Hospitals
    • Ambulatory Care Settings
    • Research Organizations
    • Others
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • South Africa
  • GCC countries
Companies Profiled
  • Landauer
  • Agfa-Gevaert Group
  • Sectra AB
  • INFINITT Healthcare Co. Ltd.
  • Bayer AG
  • PACSHealth, LLC
  • Koninklijke Philips N.V.
  • GE Healthcare
  • Thermo Fisher Scientific Inc.
  • Medsquare SAS
  • Siemens
  • Fujifilm Holdings Corporation
  • QAELUM NV
Customization Scope Available upon request
Pricing Available upon request

Frequently Asked Questions

How big was the global radiation dose management market in 2022?

It was valued at US$ 237.8 Mn in 2022

How is the radiation dose management sector expected to grow by 2031?

It is projected to expand at a CAGR of 14.8% from 2023 to 2031

What are the key factors driving the demand for radiation dose management?

Increase in health concerns over radiation exposure and rise in use of diagnostic imaging modalities

Which was the most lucrative region for radiation dose management industry in 2022?

North America was the most lucrative region in 2022

Who are the prominent radiation dose management service providers?

Landauer, Agfa-Gevaert Group, Sectra AB, INFINITT Healthcare Co. Ltd., Bayer AG, PACSHealth, LLC, Koninklijke Philips N.V., GE Healthcare, Thermo Fisher Scientific Inc., Medsquare SAS, Siemens, Fujifilm Holdings Corporation, and QAELUM NV

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Radiation Dose Management Market

4. Market Overview

    4.1. Introduction

        4.1.1. Product Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Radiation Dose Management Market Analysis and Forecast, 2017-2031

5. Key Insights

    5.1. Pipeline Analysis

    5.2. Key Product/Brand Analysis

    5.3. Key Mergers & Acquisitions

    5.4. COVID-19 Pandemic Impact on Industry

6. Global Radiation Dose Management Market Analysis and Forecast, by Product and Services

    6.1. Introduction and Definitions

    6.2. Key Findings/Developments

    6.3. Market Value Forecast, by Product and Services, 2017–2031

        6.3.1. Software

            6.3.1.1. Integrated Solution

            6.3.1.2. Standalone Solution

        6.3.2. Services

    6.4. Market Attractiveness, by Product and Services

7. Global Radiation Dose Management Market Analysis and Forecast, by Modality

    7.1. Introduction and Definitions

    7.2. Key Findings/Developments

    7.3. Market Value Forecast, by Modality, 2017–2031

        7.3.1. Computed Tomography

        7.3.2. Radiography and Mammography

        7.3.3. Fluoroscopy and Interventional Imaging

        7.3.4. Nuclear Medicine Scan

        7.3.5. Others

        7.3.6. 7.4 Market Attractiveness, by Modality

8. Global Radiation Dose Management Market Analysis and Forecast, by Application

    8.1. Introduction and Definitions

    8.2. Key Findings/Developments

    8.3. Market Value Forecast, by Application, 2017–2031

        8.3.1. Oncology

        8.3.2. Cardiology

        8.3.3. Orthopedic

        8.3.4. Others

    8.4. Market Attractiveness, by Application

9. Global Radiation Dose Management Market Analysis and Forecast, by End-user

    9.1. Introduction and Definitions

    9.2. Key Findings/Developments

    9.3. Market Value Forecast, by End-user, 2017–2031

        9.3.1. Hospitals

        9.3.2. Ambulatory Care Settings

        9.3.3. Research Organizations

        9.3.4. Others

    9.4. Market Attractiveness, by End-user

10. Global Radiation Dose Management Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value Forecast, by Region, 2017–2031

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa

    10.3. Market Attractiveness, by Region

11. North America Radiation Dose Management Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Product and Services, 2017–2031

        11.2.1. Software

            11.2.1.1. Integrated Solution

            11.2.1.2. Standalone Solution

        11.2.2. Services

    11.3. Market Attractiveness, by Product and Services

    11.4. Market Value Forecast, by Modality, 2017–2031

        11.4.1. Computed Tomography

        11.4.2. Radiography and Mammography

        11.4.3. Fluoroscopy and Interventional Imaging

        11.4.4. Nuclear Medicine Scan

        11.4.5. Others

    11.5. Market Attractiveness, by Modality

    11.6. Market Value Forecast, by Application, 2017–2031

        11.6.1. Oncology

        11.6.2. Cardiology

        11.6.3. Orthopedic

        11.6.4. Others

    11.7. Market Attractiveness, by Application

    11.8. Market Value Forecast, by End-user, 2017–2031

        11.8.1. Hospitals

        11.8.2. Ambulatory Care Settings

        11.8.3. Research Organizations

        11.8.4. Others

    11.9. Market Attractiveness, by End-user

    11.10. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.10.1. U.S.

        11.10.2. Canada

    11.11. Market Attractiveness Analysis

        11.11.1. By Product and Services

        11.11.2. By Modality

        11.11.3. By Application

        11.11.4. By End-user

        11.11.5. By Country

12. Europe Radiation Dose Management Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Product and Services, 2017–2031

        12.2.1. Software

            12.2.1.1. Integrated Solution

            12.2.1.2. Standalone Solution

        12.2.2. Services

    12.3. Market Attractiveness, by Product and Services

    12.4. Market Value Forecast, by Modality, 2017–2031

        12.4.1. Computed Tomography

        12.4.2. Radiography and Mammography

        12.4.3. Fluoroscopy and Interventional Imaging

        12.4.4. Nuclear Medicine Scan

        12.4.5. Others

    12.5. Market Attractiveness, by Modality

    12.6. Market Value Forecast, by Application, 2017–2031

        12.6.1. Oncology

        12.6.2. Cardiology

        12.6.3. Orthopedic

        12.6.4. Others

    12.7. Market Attractiveness, by Application

    12.8. Market Value Forecast, by End-user, 2017–2031

        12.8.1. Hospitals

        12.8.2. Ambulatory Care Settings

        12.8.3. Research Organizations

        12.8.4. Others

    12.9. Market Attractiveness, by End-user

    12.10. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.10.1. Germany

        12.10.2. U.K.

        12.10.3. France

        12.10.4. Italy

        12.10.5. Spain

        12.10.6. Rest of Europe

    12.11. Market Attractiveness Analysis

        12.11.1. By Product and Services

        12.11.2. By Modality

        12.11.3. By Application

        12.11.4. By End-user

        12.11.5. By Country/Sub-region

13. Asia Pacific Radiation Dose Management Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Product and Services, 2017–2031

        13.2.1. Software

            13.2.1.1. Integrated Solution

            13.2.1.2. Standalone Solution

        13.2.2. Services

    13.3. Market Attractiveness, by Product and Services

    13.4. Market Value Forecast, by Modality, 2017–2031

        13.4.1. Computed Tomography

        13.4.2. Radiography and Mammography

        13.4.3. Fluoroscopy and Interventional Imaging

        13.4.4. Nuclear Medicine Scan

        13.4.5. Others

    13.5. Market Attractiveness, by Modality

    13.6. Market Value Forecast, by Application, 2017–2031

        13.6.1. Oncology

        13.6.2. Cardiology

        13.6.3. Orthopedic

        13.6.4. Others

    13.7. Market Attractiveness, by Application

    13.8. Market Value Forecast, by End-user, 2017–2031

        13.8.1. Hospitals

        13.8.2. Ambulatory Care Settings

        13.8.3. Research Organizations

        13.8.4. Others

    13.9. Market Attractiveness, by End-user

    13.10. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.10.1. China

        13.10.2. Japan

        13.10.3. India

        13.10.4. Australia & New Zealand

        13.10.5. Rest of Asia Pacific

    13.11. Market Attractiveness Analysis

        13.11.1. By Product and Services

        13.11.2. By Modality

        13.11.3. By Application

        13.11.4. By End-user

        13.11.5. By Country/Sub-region

14. Latin America Radiation Dose Management Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Product and Services, 2017–2031

        14.2.1. Software

            14.2.1.1. Integrated Solution

            14.2.1.2. Standalone Solution

        14.2.2. Services

    14.3. Market Attractiveness, by Product and Services

    14.4. Market Value Forecast, by Modality, 2017–2031

        14.4.1. Computed Tomography

        14.4.2. Radiography and Mammography

        14.4.3. Fluoroscopy and Interventional Imaging

        14.4.4. Nuclear Medicine Scan

        14.4.5. Others

    14.5. Market Attractiveness, by Modality

    14.6. Market Value Forecast, by Application, 2017–2031

        14.6.1. Oncology

        14.6.2. Cardiology

        14.6.3. Orthopedic

        14.6.4. Others

    14.7. Market Attractiveness, by Application

    14.8. Market Value Forecast, by End-user, 2017–2031

        14.8.1. Hospitals

        14.8.2. Ambulatory Care Settings

        14.8.3. Research Organizations

        14.8.4. Others

    14.9. Market Attractiveness, by End-user

    14.10. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.10.1. Brazil

        14.10.2. Mexico

        14.10.3. Rest of Latin America

    14.11. Market Attractiveness Analysis

        14.11.1. By Product and Services

        14.11.2. By Modality

        14.11.3. By Application

        14.11.4. By End-user

        14.11.5. By Country/Sub-region

15. Middle East & Africa Radiation Dose Management Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Product and Services, 2017–2031

        15.2.1. Software

            15.2.1.1. Integrated Solution

            15.2.1.2. Standalone Solution

        15.2.2. Services

    15.3. Market Attractiveness, by Product and Services

    15.4. Market Value Forecast, by Modality, 2017–2031

        15.4.1. Computed Tomography

        15.4.2. Radiography and Mammography

        15.4.3. Fluoroscopy and Interventional Imaging

        15.4.4. Nuclear Medicine Scan

        15.4.5. Others

    15.5. Market Attractiveness, by Modality

    15.6. Market Value Forecast, by Application, 2017–2031

        15.6.1. Oncology

        15.6.2. Cardiology

        15.6.3. Orthopedic

        15.6.4. Others

    15.7. Market Attractiveness, by Application

    15.8. Market Value Forecast, by End-user, 2017–2031

        15.8.1. Hospitals

        15.8.2. Ambulatory Care Settings

        15.8.3. Research Organizations

        15.8.4. Others

    15.9. Market Attractiveness, by End-user

    15.10. Market Value Forecast, by Country/Sub-region, 2017–2031

        15.10.1. GCC Countries

        15.10.2. South Africa

        15.10.3. Rest of Middle East & Africa

    15.11. Market Attractiveness Analysis

        15.11.1. By Product and Services

        15.11.2. By Modality

        15.11.3. By Application

        15.11.4. By End-user

        15.11.5. By Country/Sub-region

16. Competition Landscape

    16.1. Market Player -Competition Matrix (By Tier and Size of Companies)

    16.2. Market Share Analysis, by Company (2022)

    16.3. Company Profiles

        16.3.1. Landauer

            16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.1.2. Product Portfolio

            16.3.1.3. Financial Overview

            16.3.1.4. SWOT Analysis

            16.3.1.5. Strategic Overview

        16.3.2. Agfa-Gevaert Group

            16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.2.2. Product Portfolio

            16.3.2.3. Financial Overview

            16.3.2.4. SWOT Analysis

            16.3.2.5. Strategic Overview

        16.3.3. Sectra AB

            16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.3.2. Product Portfolio

            16.3.3.3. Financial Overview

            16.3.3.4. SWOT Analysis

            16.3.3.5. Strategic Overview

        16.3.4. INFINITT Healthcare Co. Ltd.

            16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.4.2. Product Portfolio

            16.3.4.3. Financial Overview

            16.3.4.4. SWOT Analysis

            16.3.4.5. Strategic Overview

        16.3.5. Bayer AG

            16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.5.2. Product Portfolio

            16.3.5.3. Financial Overview

            16.3.5.4. SWOT Analysis

            16.3.5.5. Strategic Overview

        16.3.6. PACSHealth, LLC

            16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.6.2. Product Portfolio

            16.3.6.3. Financial Overview

            16.3.6.4. SWOT Analysis

            16.3.6.5. Strategic Overview

        16.3.7. Koninklijke Philips N.V.

            16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.7.2. Product Portfolio

            16.3.7.3. Financial Overview

            16.3.7.4. SWOT Analysis

            16.3.7.5. Strategic Overview

        16.3.8. GE Healthcare

            16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.8.2. Product Portfolio

            16.3.8.3. Financial Overview

            16.3.8.4. SWOT Analysis

            16.3.8.5. Strategic Overview

        16.3.9. Thermo Fisher Scientific, Inc.

            16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.9.2. Product Portfolio

            16.3.9.3. Financial Overview

            16.3.9.4. SWOT Analysis

            16.3.9.5. Strategic Overview

        16.3.10. Medsquare SAS

            16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.10.2. Product Portfolio

            16.3.10.3. Financial Overview

            16.3.10.4. SWOT Analysis

            16.3.10.5. Strategic Overview

        16.3.11. Siemens

            16.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.11.2. Product Portfolio

            16.3.11.3. Financial Overview

            16.3.11.4. SWOT Analysis

            16.3.11.5. Strategic Overview

        16.3.12. Fujifilm Holdings Corporation

            16.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.12.2. Product Portfolio

            16.3.12.3. Financial Overview

            16.3.12.4. SWOT Analysis

            16.3.12.5. Strategic Overview

        16.3.13. QAELUM NV

            16.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.3.13.2. Product Portfolio

            16.3.13.3. Financial Overview

            16.3.13.4. SWOT Analysis

            16.3.13.5. Strategic Overview

List of Tables

Table 01: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 02: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 03: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 04: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Radiation Dose Management Market Size (US$ Mn) Forecast, by Region, 2017–2031

Table 06: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country, 2017–2031

Table 07: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 08: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 9: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 10: North America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 11: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 12: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 13: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 14: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 15: Europe Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 16: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 18: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 19: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 20: Asia Pacific Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 21: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 22: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 23: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 24: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 25: Latin America Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 27: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Product and Services, 2017–2031

Table 28: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Modality, 2017–2031

Table 29: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by Application, 2017–2031

Table 30: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Radiation Dose Management Market Size (US$ Mn), by Region, 2022 and 2031

Figure 02: Global Radiation Dose Management Market Revenue (US$ Mn), by Product and Services, 2022

Figure 03: Global Radiation Dose Management Market Value Share, by Product and Services, 2022

Figure 04: Global Radiation Dose Management Market Revenue (US$ Mn), by Modality, 2022

Figure 05: Global Radiation Dose Management Market Value Share, by Modality, 2022

Figure 06: Global Radiation Dose Management Market Revenue (US$ Mn), by Application, 2022

Figure 07: Global Radiation Dose Management Market Value Share, by Application, 2022

Figure 08: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022

Figure 09: Global Radiation Dose Management Market Value Share, by End-user, 2022

Figure 10: Global Radiation Dose Management Market Value Share, by Region, 2022

Figure 11: Global Radiation Dose Management Market Value (US$ Mn) Forecast, 2017–2031

Figure 12: Global Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 13: Global Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023-2031

Figure 14: Global Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 15: Global Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023-2031

Figure 16: Global Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 17: Global Radiation Dose Management Market Attractiveness Analysis, by Application, 2023-2031

Figure 18: Global Radiation Dose Management Market Revenue (US$ Mn), by End-user, 2022

Figure 19: Global Radiation Dose Management Market Value Share, by End-user, 2022

Figure 20: Global Radiation Dose Management Market Value Share Analysis, by Region, 2022 and 2031

Figure 21: Global Radiation Dose Management Market Attractiveness Analysis, by Region, 2023-2031

Figure 22: North America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 23: North America Radiation Dose Management Market Attractiveness Analysis, by Country, 2023–2031

Figure 24: North America Radiation Dose Management Market Value Share Analysis, by Country, 2022 and 2031

Figure 25: North America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 26: North America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 27: North America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 28: North America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

Figure 29: North America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

Figure 30: North America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

Figure 31: North America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

Figure 32: North America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

Figure 33: Europe Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 34: Europe Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 35: Europe Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 36: Europe Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 37: Europe Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 38: Europe Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 39: Europe Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

Figure 40: Europe Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

Figure 41: Europe Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

Figure 42: Europe Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

Figure 43: Europe Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

Figure 44: Asia Pacific Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 45: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 46: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 47: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 48: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 49: Asia Pacific Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 50: Asia Pacific Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

Figure 51: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

Figure 52: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

Figure 53: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

Figure 54: Asia Pacific Radiation Dose Management Market Attractiveness Analysis, by End-user, 2022–2031

Figure 55: Latin America Radiation Dose Management Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 56: Latin America Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 57: Latin America Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 58: Latin America Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 59: Latin America Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 60: Latin America Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 61: Latin America Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

Figure 62: Latin America Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

Figure 63: Latin America Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

Figure 64: Latin America Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

Figure 65: Latin America Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

Figure 66: Middle East & Africa Radiation Dose Management Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031

Figure 67: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Country/Sub-region, 2023–2031

Figure 68: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

Figure 69: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Product and Services, 2022 and 2031

Figure 70: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Modality, 2022 and 2031

Figure 71: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by Application, 2022 and 2031

Figure 72: Middle East & Africa Radiation Dose Management Market Value Share Analysis, by End-user, 2022 and 2031

Figure 73: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Product and Services, 2023–2031

Figure 74: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Modality, 2023–2031

Figure 75: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by Application, 2023–2031

Figure 76: Middle East & Africa Radiation Dose Management Market Attractiveness Analysis, by End-user, 2023–2031

Copyright © Transparency Market Research, Inc. All Rights reserved